Scientists push back on 'natural means safe' messaging for BPC-157, and some new FDA panel members who backed looser rules sell peptides themselves.
Recap by typeshit. Full story at The Good Men Project.
A patient stopped Wegovy for weeks around surgery and asks others whether symptoms returned when they came off it.
One user says her period returned after two months on tirzepatide without medroxyprogesterone and asks others to compare.
She singles out products sold as retatrutide as especially dangerous, part of the growing pushback on gray-market peptide sellers.
In Touch Weekly reports the March 2025 death was caused by anaphylaxis and was Australia's first death of its kind linked to anti-aging drugs.
She landed the Daily Mail front page this week discussing Ozempic face and the steps she says she took to protect her own.
Dr. Shah walks through how GLP-1s work, who stands to benefit, common side effects, and NorthShore's weight management clinic.
Loading…